0
     

Report Added
Report already added
Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026

Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026

The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period”. The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices, increase in the aging population with osteoarthritis, strong focus of players towards launch of highly advanced arthroscopic treatment devices. On the other hand, a dearth of skilled professionals, a high surgical treatment failure rate, and its high cost are major challenges faced by market players providing rotator cuff injury treatment products.

The COVID-19 pandemic is an unprecedented crisis that has significantly strained healthcare providers, healthcare infrastructure, and healthcare systems worldwide. The COVID-19 pandemic had a remarkable change in several aspects of medical practice. Elective surgeries, including orthopedic surgery, were canceled worldwide, allowing hospitals to accommodate more COVID-19 patients and completely focus on reducing the possible risk of infection among healthcare workers.

According to The CovidSurg Collaborative, a 120-country research initiative formed to analyze the impact of the COVID-19 pandemic on surgeries, around 28.4 million elective surgeries worldwide will be canceled or postponed in 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19. The rotator cuff injury treatment market was also impacted due to restrictions on the organized temporary closure of surgical centers, hospital access restriction for non-essential care, limited access to clinics, implementation of social distancing measures, nationwide lockdowns, and the slowdown of in-patient flow and referrals.

“The surgical or curative treatment to capture the largest share in rotator cuff injury treatment market, by type during the forecast period.”

The surgical treatment segment is expected to hold the largest share of rotator cuff injury treatment market, during the forecast period. This is attributable to the high adoption due to the increasing prevalence of rotator cuff injuries majorly among sportspersons, rising awareness activities by major market players across key countries, and the availability of medical reimbursements for surgical treatment of rotator cuff rupture. Additionally, the increase in the preference of shoulder arthroscopy for the treatment rotator cuff tear among surgeons and the growing awareness about the benefits associated with arothrocopic repair such as lower risk of complications, quick recovery, low rate of post surgical infections are likely to play a significant role in propelling the growth of the segment.

“The Asia Pacific market to grow at the highest CAGR during the forecast period.”

The rotator cuff injury treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. significant increase in its geriatric and patient population for orthopedic diseases, growing adoption of orthopedic bracing products in developing nations of Asia Pacific, growing presence of rotator cuff injury treatment devices and drugs manufacturers in the country, increase in the initiatives by the government to promote sports, and growing adoption of new surgical devices for rotator cuff tears launched by local manufacturers are likely to support the growth of the market in the region.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, D-level: 30%, and Others: 44%
• By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%

Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra LifeSciences Corporation (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US).

Research Coverage
This report studies the global rotator cuff injury treatment market based on the treatment type, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global in rotator cuff injury treatment market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Table of Contents

1INTRODUCTION14
1.1OBJECTIVES OF THE STUDY14
1.2MARKET DEFINITION14
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY15
1.3MARKET SCOPE15
1.3.1MARKETS COVERED15
1.3.2YEARS CONSIDERED FOR THE STUDY16
1.4CURRENCY USED FOR THE STUDY16
1.5MAJOR MARKET STAKEHOLDERS16
2RESEARCH METHODOLOGY17
2.1RESEARCH DATA17
FIGURE 1RESEARCH DESIGN17
2.1.1SECONDARY DATA SOURCES18
2.1.1.1Secondary Data Sources19
2.1.2PRIMARY DATA SOURCES20
FIGURE 2BREAKDOWN OF PRIMARIES: ROTATOR CUFF RUPTURE TREATMENT MARKET20
2.2MARKET ESTIMATION METHODOLOGY20
FIGURE 3RESEARCH METHODOLOGY: HYPOTHESIS BUILDING21
2.2.1REVENUE MAPPING-BASED MARKET ESTIMATION21
2.2.2TREATMENT USAGE-BASED MARKET ESTIMATION22
FIGURE 4MARKET SIZE ESTIMATION BASED ON TREATMENT UTILIZATION METHODOLOGY22
FIGURE 5MARKET SIZE ESTIMATION BASED ON REVENUE MAPPING METHODOLOGY23
2.2.3PRIMARY RESEARCH VALIDATION23
2.3DATA TRIANGULATION24
FIGURE 6DATA TRIANGULATION METHODOLOGY24
2.4RESEARCH ASSUMPTIONS25
2.5RESEARCH LIMITATIONS25
3EXECUTIVE SUMMARY26
3.1ROTATOR CUFF RUPTURE TREATMENT MARKET26
FIGURE 7ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)26
FIGURE 8MARKET OPPORTUNITY IN ROTATOR CUFF RUPTURE TREATMENT MARKET DURING 2020-2026 (USD MN)27
4MARKET OVERVIEW28
4.1INTRODUCTION28
4.2MARKET DYNAMICS28
4.2.1INDUSTRY GROWTH OPPORTUNITIES28
4.2.1.1Rising number of sports-related shoulder injuries28
FIGURE 9INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US PER 1000 INHABITANATS (2020)29
4.2.1.2Technological advancements in rotator cuff rupture devices30
4.2.1.3Growing public-private funding grants and educational awareness initiatives30
4.2.1.4Increasing risk of osteoarthritis in the geriatric population31
TABLE 1NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION (2019 VS. 2050)32
4.2.1.5Growing developments in orthobiologics32
4.2.2BURNING ISSUES AND CHALLENGES33
4.2.2.1High costs associated with arthroscopic surgical procedures33
4.2.2.2High failure rates of rotator cuff surgical treatment33
4.2.2.3Shortage of trained orthopedic professionals33
4.2.3COVID-19 SPECIFIC TRENDS34
4.3REGULATORY LANDSCAPE34
4.3.1NORTH AMERICA34
4.3.1.1US34
TABLE 2US FDA: MEDICAL DEVICE CLASSIFICATION35
TABLE 3US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS35
4.3.1.2Canada36
TABLE 4CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS36
FIGURE 10CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (CMDR)37
4.3.2EUROPE37
FIGURE 11EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)39
4.3.3ASIA PACIFIC39
4.3.3.1India39
4.3.3.2Japan39
TABLE 5JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA40
4.3.3.3China40
TABLE 6CHINA: CLASSIFICATION OF MEDICAL DEVICES40
4.3.3.4India41
4.4REIMBURSEMENT SCENARIO42
TABLE 7REIMBURSEMENT CODES FOR PHYSICIAN SERVICES (AS OF 2020)42
TABLE 8REIMBURSEMENT CODES FOR OUTPATIENT SERVICES (AS OF 2020)42
4.5PRICING TREND ANALYSIS43
TABLE 9AVERAGE PRICE OF ROTATOR CUFF TREATMENT INSTRUMENTS, BY REGION COUNTRY, 2020 (USD)43
4.6CLINICAL RESEARCH PIPELINE44
4.6.1ROTATOR CUFF REPAIR TREATMENT44
TABLE 10ROTATOR CUFF REPAIR: INDICATIVE LIST OF ONGOING CLINICAL TRIALS
(AS OF 2021)44
4.7PATENT ANALYSIS49
FIGURE 12TOP 10 PATENT APPLICANTS FOR ROTATOR CUFF REPAIR
(JANUARY 2011 TO OCTOBER 2021)49
FIGURE 13NUMBER OF GRANTED PATENTS AND PATENT APPLICATIONS
(JANUARY 2011 TO OCTOBER 2021)50
FIGURE 14PATENT DOCUMENTS FOR ROTATOR CUFF REPAIR, BY LEGAL STATUS (JANUARY 2011 TO OCTOBER 2021)50
FIGURE 15REGIONAL ANALYSIS OF PATENTS GRANTED FOR ROTATOR CUFF REPAIR, 202050
5ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE51
5.1INTRODUCTION52
TABLE 11ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)52
5.2SURGICAL OR CURATIVE TREATMENT52
5.2.1TRADITIONAL/OPEN SURGERIES52
5.2.1.1Shoulder replacement surgeries53
5.2.1.2Open tendon repair/transfer53
5.2.2ARTHROSCOPY (TENDON REPAIR)53
TABLE 12ARTHOSCOPY TREATMENT MARKET, BY REGION, 2019–2026 (USD MILLION)54
5.3PHYSIOTHERAPY OR PALLIATIVE TREATMENT54
TABLE 13PHYSIOTHERAPY TREATMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)54
5.3.1ORTHOPEDIC BRACES55
TABLE 14ORTHOPEDIC BRACES MARKET, BY REGION, 2019–2026 (USD MILLION)55
5.3.2COLD COMPRESSION THERAPY55
TABLE 15COLD COMPRESSION THERAPY MARKET, BY REGION,
2019–2026 (USD MILLION)56
5.4PHARMACEUTICAL DRUGS OR PREVENTIVE TREATMENT56
TABLE 16PHARMACEUTICAL DRUGS MARKET, BY TYPE, 2019–2026 (USD MILLION)56
5.4.1ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS57
TABLE 17ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS MARKET,
2019–2026 (USD MILLION)57
5.4.2INJECTIONS57
TABLE 18INJECTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)58
5.5ORTHOBIOLOGICS58
TABLE 19ORTHOBIOLOGICS MARKET, BY TYPE, 2019–2026 (USD MILLION)58
6ROTATOR CUFF RUPTURE TREATMENT MARKET, BY REGION59
6.1INTRODUCTION59
TABLE 20ROTATOR CUFF RUPTURE TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION)59
6.2NORTH AMERICA59
TABLE 21NORTH AMERICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)60
6.3EUROPE61
TABLE 22EUROPE ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)61
6.4ASIA PACIFIC62
TABLE 23ASIA PACIFIC ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)63
6.5LATIN AMERICA63
TABLE 24LATIN AMERICA ROTATOR CUFF RUPTURE TREATMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)64
6.6MIDDLE EAST & AFRICA64
TABLE 25MIDDLE EAST & AFRICA ROTATOR CUFF RUPTURE TREATMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION)64
7COMPETITIVE LANDSCAPE65
7.1OVERVIEW65
7.1.1KEY PLAYER STRATEGIES65
7.2LIST OF KEY PLAYERS OPERATING IN EACH TREATMENT SPACE66
7.2.1PRODUCT PORTFOLIO/DEVELOPMENT PIPELINE67
7.2.2KEY STRATEGIES/RIGHT TO WIN69
7.3COMPETITIVE SCENARIO71
7.3.1ROTATOR CUFF RUPTURE TREATMENT MARKET: PRODUCT LAUNCHES & REGULATORY APPROVALS71
TABLE 26KEY PRODUCT LAUNCHES & REGULATORY APPROVALS,
JANUARY 2018–OCTOBER 202171
7.3.2ROTATOR CUFF RUPTURE TREATMENT MARKET: DEALS71
TABLE 27KEY DEALS, JANUARY 2018–OCTOBER 202171
7.3.3ROTATOR CUFF RUPTURE TREATMENT MARKET: OTHER DEVELOPMENTS72
TABLE 28OTHER KEY DEVELOPMENTS, JANUARY 2018–OCTOBER 202172
7.3.4COMPETITIVE LEADERSHIP MAPPING72
7.3.4.1Stars72
7.3.4.2Pervasive players73
7.3.4.3Emerging leaders73
7.3.4.4Participants73
FIGURE 16ROTATOR CUFF RUPTURE TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 202073
7.4FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF RUPTURE TREATMENT MARKET74
7.4.1TREATMENT PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF RUPTURE TREATMENT MARKET74
TABLE 29TREATMENT PRODUCT FOOTPRINT OF COMPANIES74
TABLE 30REGIONAL FOOTPRINT OF COMPANIES75
8COMPANY PROFILES76
8.1KEY PLAYERS76
(Business overview, Products offered, Recent developments, and MnM view)*
8.1.1STRYKER CORPORATION76
TABLE 31STRYKER CORPORATION: BUSINESS OVERVIEW76
FIGURE 17STRYKER CORPORATION: COMPANY SNAPSHOT (2020)77
8.1.2JOHNSON & JOHNSON80
TABLE 32JOHNSON & JOHNSON: BUSINESS OVERVIEW80
FIGURE 18JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)81
8.1.3SMITH & NEPHEW83
TABLE 33SMITH & NEPHEW: BUSINESS OVERVIEW83
FIGURE 19SMITH & NEPHEW: COMPANY SNAPSHOT (2020)84
8.1.4ARTHREX87
TABLE 34ARTHREX: BUSINESS OVERVIEW87
8.1.5ZIMMER BIOMET89
TABLE 35ZIMMER BIOMET: BUSINESS OVERVIEW89
FIGURE 20ZIMMER BIOMET: COMPANY SNAPSHOT (2020)90
8.1.6INTEGRA LIFESCIENCES92
TABLE 36INTEGRA LIFESCIENCES: BUSINESS OVERVIEW92
FIGURE 21INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)93
8.1.7LIMACORPORATE S.P.A94
TABLE 37LIMACORPORATE: BUSINESS OVERVIEW94
FIGURE 22LIMACORPORATE: COMPANY SNAPSHOT (2020)94
8.1.8DJO GLOBAL, INC.96
TABLE 38DJO GLOBAL, INC.: BUSINESS OVERVIEW96
FIGURE 23DJO GLOBAL, INC.: COMPANY SNAPSHOT (2020)97
8.1.9EVOLUTIS99
TABLE 39EVOLUTIS: BUSINESS OVERVIEW99
8.1.10GROUP FH ORTHO100
TABLE 40GROUP FH ORTHO: BUSINESS OVERVIEW100
8.1.11CONMED CORPORATION102
TABLE 41CONMED CORPORATION: BUSINESS OVERVIEW102
FIGURE 24CONMED CORPORATION: COMPANY SNAPSHOT (2020)103
8.1.123S ORTHO105
TABLE 423S ORTHO: BUSINESS OVERVIEW105
8.1.13ANIKA THERAPEUTICS, INC. (PARCUS MEDICAL)106
TABLE 43ANIKA THERAPEUTICS: BUSINESS OVERVIEW106
FIGURE 25ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2020)107
8.1.14GPC MEDICAL LTD.109
TABLE 44GPC MEDICAL LTD.: BUSINESS OVERVIEW109
8.1.15BREG, INC.110
TABLE 45BREG, INC.: BUSINESS OVERVIEW110
*Details on Business overview, Products offered, Recent developments, and MnM view not be captured in case of unlisted companies.
9APPENDIX112
9.1DISCUSSION GUIDE112
9.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL115
9.3RELATED REPORTS117
9.4AVAILABLE CUSTOMIZATIONS118

Report Title: Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW